FlyBase Human Disease Model Report Index

• 3-methylglutaconic aciduria
• 46,XX sex reversal 4
• 46,XY gonadal dysgenesis (postulated), STARD8-related
• acute myeloid leukemia
  • acute myeloid leukemia, KRAS[G12V] model
  • acute myeloid leukemia, MLF1-related
  • acute myeloid leukemia, MLL-AF fusions
  • acute myeloid leukemia, NUP98-HOXA9 fusion
  • acute myeloid leukemia, RUNX1-RUNX1T1 fusion
  • acute myeloid leukemia models, RAS-Scrib-complex-related
• acyl-CoA dehydrogenase, medium chain, deficiency of
• Adams-Oliver syndrome 3
• adenoid cystic carcinoma, multigenic, personalized
• adrenoleukodystrophy, ABCD1-related
• adrenoleukodystrophy (postulated), ACSBG-related
• advanced sleep phase syndrome
  • familial advanced sleep phase syndrome 2
• age-dependent ectopic fat accumulation, HDAC6-related
• Alexander disease
• alcohol use disorder, susceptibility to (fly models overview)
  • alcohol, developmental effects
  • alcohol, increased aggressive behavior
  • alcohol, response to, actin-mediated
  • alcohol, response to, AKAP-related
  • alcohol, response to, ARF6-related
  • alcohol, response to, ATG16L-related
  • alcohol, response to, AUTS2-related
  • alcohol, response to, cathepsin-related
  • alcohol, response to, CBP-related
  • alcohol, response to, Crz neuropeptide-related
  • alcohol, response to, Dmel_apt-related
  • alcohol, response to, dopamine receptor DRD1,5-related
  • alcohol, response to, dual-GPCR signaling
  • alcohol, response to, EGFR-MAPK/ERK signaling
  • alcohol, response to, EPS8-related
  • alcohol, response to, F-actin turnover-related
  • alcohol, response to, GABBR-related
  • alcohol, response to, GRK4,5,6-related
  • alcohol, response to, GSTO-related
  • alcohol, response to, HOMER-related
  • alcohol, response to, INSR-related
  • alcohol, response to, insulin signaling pathway
  • alcohol, response to, JmjC-domain-containing genes
  • alcohol, response to, KCNMA1-related
  • alcohol, response to, learning and memory genes
  • alcohol, response to, MAP4K-related
  • alcohol, response to, MEF2-related
  • alcohol, response to, microRNA-related
  • alcohol, response to, NMDA-receptor-mediated
  • alcohol, response to, NPY-related
  • alcohol, response to, PI3K-AKT signaling pathway
  • alcohol, response to, PSD-related
  • alcohol, response to, RhoGAP-related
  • alcohol, response to, RPS6KB-related
  • alcohol, response to, RSU1-related
  • alcohol, response to, RYR-related
  • alcohol, response to, stress-response genes
  • alcohol, response to, SIRT1-related
  • alcohol, response to, SLC39A8-related
  • alcohol, response to, UNC13A-related
  • alcohol, response to, XRCC5-related
  • persistent alcohol cue memory
• Alpers-Huttenlocher syndrome
• alpha-1-antitrypsin deficiency
• Alzheimer disease
  • Alzheimer disease 1
  • Alzheimer disease 2
  • Alzheimer disease, APP-BACE1-related
  • Alzheimer disease, presenilin-related
    • Alzheimer disease 3
    • Alzheimer disease 4
  • Alzheimer disease, retromer dysfunction
  • Alzheimer disease, susceptibility to, CD2AP-related
  • Alzheimer disease, susceptibility to, FERMT2-related
  • Alzheimer disease, susceptibility to, PICALM-related
  • Alzheimer disease, susceptibility to, TOMM40-related
  • Alzheimer disease, susceptibility to (postulated), CELF1-related
  • Alzheimer disease, susceptibility to (postulated), GCAT-related
  • Alzheimer disease, susceptibility to (postulated), ITGAM-ITGA9-related
  • Alzheimer disease, susceptibility to (postulated), MAST4-related
  • Alzheimer disease, susceptibility to (postulated), NCSTN-related
  • Alzheimer disease, susceptibility to (postulated), PLD3-related
  • Alzheimer disease, susceptibility to (postulated), PTPRD-related
  • Alzheimer disease, susceptibility to (postulated), SLC2A14-related
  • Alzheimer disease, susceptibility to (postulated), SNRPN-related
  • Alzheimer disease, susceptibility to (postulated), TM2D3-related
  • Alzheimer disease, susceptibility to (postulated), XYLT1-related
• amyloidosis, familial visceral
  • amyloidosis, familial visceral, LYZ-related
• amyloidosis, hereditary, transthyretin-related
• amyotrophic lateral sclerosis
  • amyotrophic lateral sclerosis 1
  • amyotrophic lateral sclerosis 2, juvenile
  • amyotrophic lateral sclerosis 4, juvenile
  • amyotrophic lateral sclerosis 6 with or without frontotemporal dementia
  • amyotrophic lateral sclerosis 8
  • amyotrophic lateral sclerosis 10 with or without frontotemporal dementia
  • amyotrophic lateral sclerosis 11
  • spinocerebellar ataxia 2 (ALS13)
  • amyotrophic lateral sclerosis 15 with or without frontotemporal dementia
  • amyotrophic lateral sclerosis 16 (postulated)
  • amyotrophic lateral sclerosis 18
  • amyotrophic lateral sclerosis 20
  • amyotrophic lateral sclerosis 21
  • amyotrophic lateral sclerosis, susceptibilty to, 25
  • amyotrophic lateral sclerosis (postulated), EWSR1-related
  • amyotrophic lateral sclerosis (postulated), RAPGEF2-related
  • amyotrophic lateral sclerosis (postulated), SS18L1-related
  • frontotemporal dementia and/or amyotrophic lateral sclerosis 1
  • frontotemporal dementia and/or amyotrophic lateral sclerosis 2
  • frontotemporal dementia and/or amyotrophic lateral sclerosis 3
  • frontotemporal dementia and/or amyotrophic lateral sclerosis 4
  • frontotemporal dementia and/or amyotrophic lateral sclerosis 6
  • frontotemporal dementia and/or amyotrophic lateral sclerosis 7
  • frontotemporal dementia and/or amyotrophic lateral sclerosis, TAF15-related
• anesthesia, response and mechanisms
  • anesthesia, response and mechanisms, PLD2-related
  • anesthesia, response and mechanisms, RYR-related
  • anesthesia, response and mechanisms, syntaxin-related
• Angelman syndrome
• anxiety modulators, fly wall-following model
• anxiety modulator(s), serotonin class 2 receptor(s)
• anxiety modulator(s), genes affecting actin filament stability
• anxiety modulator(s), CCK-like receptors
• ARC syndrome
  • arthrogryposis, renal dysfunction, and cholestasis 1
  • arthrogryposis, renal dysfunction, and cholestasis 2
• arrhythmogenic right ventricular dysplasia 5
• arthrogryposis, distal
  • arthrogryposis, distal, type 1, MYH3-related
  • arthrogryposis, distal, type 1A
  • arthrogryposis, distal, type 2A
  • arthrogryposis, distal, type 2B3
• Aspergillus species infection
• asthma, susceptibility to, ORMDL3-related
• ataxia-telangiectasia
• atrial septal defect
  • atrial septal defect 4
• attention deficit hyperactivity disorder, susceptibility to
  • attention deficit hyperactivity disorder, susceptibility to (postulated), ADGRL3-related
  • attention deficit hyperactivity disorder, susceptibility to (postulated), FBXO25-related
  • attention deficit hyperactivity disorder, susceptibility to (postulated), MEF2C-related
  • attention deficit hyperactivity disorder, susceptibility to (postulated), SLC6A3-related
  • attention deficit hyperactivity disorder, susceptibility to (postulated), TRAPPC9-related
  • attention deficit hyperactivity disorder, susceptibility to (postulated), VPS4A-related
• auditory neuropathy, autosomal dominant 1
• autism co-occurence with schizophrenia
• autism spectrum disorder, susceptibility to
  • autism, environmental risk, BPA exposure
  • autism spectrum disorder, susceptibility to, ASH1-related
  • autism spectrum disorder, susceptibility to, CHD1,2-related
  • autism spectrum disorder, susceptibility to, CHD6-9-related
    • autism spectrum disorder, susceptibility to, 18
  • autism spectrum disorder, susceptibility to, CSDE1-related
  • autism spectrum disorder, susceptibility to, de novo coding mutations (postulated)
  • autism spectrum disorder, susceptibility to, KDM5-related
  • autism spectrum disorder, susceptibility to, NBEA-related
  • autism spectrum disorder, susceptibility to, NLGN-related
    • autism spectrum disorder, susceptibility to, 20
    • autism spectrum disorder, susceptibility to, X-linked 1
    • autism spectrum disorder, susceptibility to, X-linked 2
  • autism spectrum disorder, susceptibility to, NRXN-related
  • autism spectrum disorder, susceptibility to, RIMS-related
  • autism spectrum disorder, susceptibility to, SHANK-related
    • autism spectrum disorder, susceptibility to, 17
  • autism spectrum disorder, susceptibility to, SLC9A6,9-related
    • autism spectrum disorder, susceptibility to, 16
  • autism spectrum disorder, susceptibility to, TSC1-related
  • autism spectrum disorder, susceptibility to, UBE3A-related
  • autism spectrum disorder, susceptibility to, WDFY3,4-related
  • autism spectrum disorder, susceptibility to (postulated), ABCA-related
  • autism spectrum disorder, susceptibility to (postulated), MAPK3-related
  • autism spectrum disorder, susceptibility to (postulated), NDST-related
  • autism spectrum disorder, susceptibility to (postulated), SLC6A3-related
  • autism spectrum disorder, susceptibility to (postulated), TAOK2-related
  • autism spectrum disorder, susceptibility to (postulated), TOP3B-related
  • autism spectrum disorder, susceptibility to (postulated), TRPC6-related
  • autism spectrum disorder with intellectual disability and seizures (postulated), SCAMP5-related
  • White-Sutton syndrome
• azoospermia, non-obstructive
  • azoospermia, Sertoli-cell-only syndrome, DDX3-related
  • azoospermia (postulated), CDC42BPA-related
  • azoospermia (postulated), DMRT2-related
  • azoospermia (postulated), ESRRB-ESRRG-related
  • azoospermia (postulated), NDST1-related
  • azoospermia (postulated), PTPRD-related
  • azoospermia (postulated), SNRPA1-related
  • azoospermia (postulated), TDRKH-related
  • azoospermia (postulated), TEX10-related
  • azoospermia (postulated), TEX13A-related
  • azoospermia (postulated), YIPF5-related
  • azoospermia (postulated), ZFAND3-related
  • azoospermia (postulated), ZNF622-related
  • azoospermia and testicular cancer (postulated), RBBP7-related
  • azoospermia and testicular germ cell cancer (postulated), FOXN3-related
  • azoospermia associated with Bardet-Biedl syndrome, SCAPER-related
• Barth syndrome
• basal cell carcinoma, SMO-related
• Becker muscular dystrophy
• Birt-Hogg-Dube syndrome
• Bloom syndrome
• Boucher-Neuhauser syndrome
• brachycephaly, trichomegaly, and developmental delay
• branchiootorenal spectrum disorders, EYA1-related
  • branchiootorenal syndrome 1
  • branchiootic syndrome 1
• Brown-Vialetto-Van Laere syndrome 1
• Brown-Vialetto-Van Laere syndrome 2
• calcium-induced neurotoxicity, TRP-channel-related
• cancer, general (fly models overview)
  • acute myeloid leukemia
    • acute myeloid leukemia, MLF1-related
    • acute myeloid leukemia, MLL-AF fusions
    • acute myeloid leukemia, NUP98-HOXA9 fusion
    • acute myeloid leukemia, RUNX1-RUNX1T1 fusion
    • acute myeloid leukemia models, RAS-Scrib-complex-related
  • adenoid cystic carcinoma, multigenic, personalized
  • azoospermia and testicular germ cell cancer (postulated), FOXN3-related
  • basal cell carcinoma, SMO-related
  • cachexia, IGFBP-related
  • cachexia, RAS-SCRIB larval model
  • cachexia, yki-induced eye tumor model
  • cachexia, yki-induced ISC tumor model
  • cancer, aerobic glycolysis (Warburg effect), larval growth model
  • cancer, epithelial, ABL-related
  • cancer, epithelial, AFDN-SCRIB-related
  • cancer, epithelial, ALG3-related
  • cancer, epithelial, compromised apoptosis
  • cancer, epithelial, compromised apoptosis and cell-cycle checkpoint defects
  • cancer, epithelial, compromised apoptosis and DNA repair defects
  • cancer, epithelial, DLG1-related
  • cancer, epithelial, DST-related
  • cancer, epithelial, EGFR-related
  • cancer, epithelial, EGFR-Dmel_psq model
  • cancer, epithelial, EGFR-Hippo-signaling
  • cancer, epithelial, EGFR-HSPG2 related
  • cancer, epithelial, EGFR-microRNA-related
  • cancer, epithelial, EGFR-SOCS-related
  • cancer, epithelial, ESCRT-complexes-related
  • cancer, epithelial, glycolytic tumor model
  • cancer, epithelial, ING1-related
  • cancer, epithelial, LLGL-related
  • cancer, epithelial, LLGL-MYC-related
  • cancer, epithelial, LLGL-YAP1-related
  • cancer, epithelial, Notch signaling, Hedgehog signaling
    • basal cell carcinoma, SMO-related
  • cancer, epithelial, NOTCH-LLGL-related
  • cancer, epithelial, NOTCH-SCRIB-related
  • cancer, epithelial, Par-complex-related
  • cancer, epithelial, RAB5-microRNA-related
  • cancer, epithelial, RAF-Hippo-signaling
  • cancer, epithelial, RAF-SCRIB-related
  • cancer, epithelial, RAS models, role of autophagy
  • cancer, epithelial, RAS-ATP6V-related
  • cancer, epithelial, RAS-DLG1-related
  • cancer, epithelial, RAS-Hippo-signaling
  • cancer, epithelial, RAS-LLGL-related
  • cancer, epithelial, RAS-PAXIP1/TP53-related
  • cancer, epithelial, RAS-SCRIB-related
  • cancer, epithelial, RAS-STK11-related
  • cancer, epithelial, RAS-TSPAN-related
  • cancer, epithelial, RPS6KA3-related
  • cancer, epithelial, SALL4-related
  • cancer, epithelial, SCRIB-hyperinsulinemia model
  • cancer, epithelial, SCRIB-LATS1,2-related
  • cancer, epithelial, SCRIB-MAPK1,3-related
  • cancer, epithelial, SCRIB-related
  • cancer, epithelial, SCRIB-YAP1-related
  • cancer, epithelial, SCRIB-ZBTB(TF)-related
  • cancer, epithelial, Scribble-complex-related
  • cancer, epithelial, SRC,CSK-related
  • cancer, epithelial, STAG1,2-related
  • cancer, epithelial, STX7,12-related
  • cancer, epithelial, TNF-DLG1-related
  • cancer, epithelial, TNF-SCRIB-related
  • cancer, epithelial, TNF-SCRIB-RAS-related
  • cancer, epithelial, Toll-receptor-related
  • cancer, gastrointestinal, susceptibility due to H. pylori infection
  • cancer, germline stem cell models
  • cancer, inherited susceptibilities to
    • Cowden syndrome 1
    • familial adenomatous polyposis
      • familial adenomatous polyposis 1
    • gastric cancer, hereditary diffuse, CDH1-related
    • juvenile polyposis syndrome, TGF-beta/BMP signaling pathway
    • Li-Fraumeni syndrome 1
    • multiple endocrine neoplasia
      • multiple endocrine neoplasia, type I
      • multiple endocrine neoplasia, type IIA
      • multiple endocrine neoplasia, type IIB
    • neuroblastoma, susceptibility to, 3
    • pituitary adenoma 1, multiple types
    • rhabdoid tumor predisposition syndrome 1
    • schwannomatosis, vestibular
    • von Hippel-Lindau syndrome
  • cancer, intercellular interactions, RAS-mito
  • cancer, intercellular interactions, RAB5-related
    • cancer, epithelial, RAB5-microRNA-related
  • cancer, intercellular interactions, SRC-related
  • cancer, intestinal dysplasia, UVRAG-related
  • cancer, intestinal stem cell models
    • cancer, intestinal stem cell, APC-RAS-related
    • cancer, intestinal stem cell, APC-RAS-SNA-related
    • cancer, intestinal stem cell, EGFR-related
    • cancer, intestinal stem cell, NOTCH-related
    • cancer, intestinal stem cell, RAS-NOTCH-related
    • cancer, intestinal stem cell, RAS-related
    • cancer, intestinal stem cell (postulated), SNX9,18,33-related
    • cancer, intestinal stem cell, SRC-related
    • cancer, ISC, intercellular feedback loop, SOX-related
  • cancer, intestinal, impact of Pseudomonas aeruginosa infection
  • cancer, invasive collective cell migration, border cell model
  • cancer, malignant glioma, AURKA/WDR62-related
  • cancer, malignant glioma, EGFR-related
  • cancer, malignant glioma, EGFR-MYC-related
  • cancer, malignant glioma, EGFR-PIK3C-related
  • cancer, malignant glioma, FGFR-TACC fusion
  • cancer, malignant glioma, H3-3A-related
  • cancer, malignant glioma, Par-complex-related
  • cancer, malignant glioma, RAS model
  • cancer, malignant glioma, RAS-PTEN-related
  • cancer, Malpighian tubule stem cell
  • cancer, mesothelial, FMR1-related
  • cancer, models of chromosomal instability
  • cancer, multiple, actin-remodeling regulators
  • cancer, multiple, ALK-related
  • cancer, multiple, apoptosis-induced proliferation
  • cancer, multiple, AXIN-related
  • cancer, multiple, BRAF-related
  • cancer, multiple, CCR4-NOT complex
  • cancer, multiple, CTNNB1-related
  • cancer, multiple, epigenetic mechanisms
  • cancer, multiple, germline-specific genes
  • cancer, multiple, HIPK-related
  • cancer, multiple, Hippo signaling pathway
  • cancer, multiple, IDH1,2-related
  • cancer, multiple, JAG-microRNA-related
  • cancer, multiple, MAP2K1,2-related
  • cancer, multiple, MAPK1,3-related
  • cancer, multiple, MYC-related
  • cancer, multiple, modulation by steroid hormone via mir-let7
  • cancer, multiple, NEK2-RAS-CSK(SRC)-related
  • cancer, multiple, NEK2-RET-related
  • cancer, multiple, Notch signaling pathway
  • cancer, multiple, NOTCH-MEF2-related
  • cancer, multiple, NOTCH-PI3K-AKT-related
  • cancer, multiple, NOTCH-SRC-related
  • cancer, multiple, PI3K-AKT signaling pathway
  • cancer, multiple, RAF-RHOGEF-related
  • cancer, multiple, RAF1-related
  • cancer, multiple, RAS with actin regulators
  • cancer, multiple, RAS-related
  • cancer, multiple, RAS-CSK(SRC)-related
  • cancer, multiple, RAS-CSK(SRC)-related with high-sugar diet
  • cancer, multiple, RAS-RHOGEF-related
  • cancer, multiple, RAS-S100A4-related
  • cancer, multiple, RAS-SRC-related
  • cancer, multiple, RAS-Vps-C complex-related
  • cancer, multiple, regulators of necrosis
  • cancer, multiple, RET fusions
    • lung cancer, adenocarcinoma, KIF5B-RET fusion
    • thyroid carcinoma, nonmedullary, CCDC6-RET fusion
    • thyroid carcinoma, nonmedullary, NCOA4-RET fusion
  • cancer, multiple, TET2-related
  • cancer, multiple, TP53-related
  • cancer, multiple, UBIAD1-related
  • cancer, multiple, WWOX-related
  • cancer, neural stem cell, AFDN-SCRIB-related
  • cancer, neural stem cell, centrosome dysfunction
  • cancer, neural stem cell, disruption of asymmetric division
  • cancer, neural stem cell, HES (bHLH TF)-related
  • cancer, neural stem cell, LLGL-related
  • cancer, neural stem cell, L3MBTL-related
  • cancer, neural stem cell, Notch-related
  • cancer, neural stem cell, NR2E1-related
  • cancer, neural stem cell, retromer tumor suppressors
  • cancer, neural stem cell, TRIM2,3-related
  • cancer, neural stem cell dedifferentiation
  • cancer, sarcoma, CIC-DUX4 fusion
  • cancer, tracheal model of angiogenesis
  • cancer therapeutic, Drosophila deoxyribonucleoside kinase
  • colorectal cancer
    • cancer, intestinal dysplasia, UVRAG-related
    • cancer, intestinal stem cell, SRC-related
    • colorectal cancer, multigenic
    • colorectal cancer, multigenic, personalized
  • colorectal cancer, personalizable in silico model
    • familial adenomatous polyposis
  • Ewing sarcoma
  • familial adenomatous polyposis
    • familial adenomatous polyposis 1
  • gastric cancer, hereditary diffuse, CDH1-related
  • gastric cancer, TPM4-ALK fusion
  • hematologic cancer (fly models overview)
    • acute myeloid leukemia
      • acute myeloid leukemia, MLF1-related
      • acute myeloid leukemia, MLL-AF fusions
      • acute myeloid leukemia, NUP98-HOXA9 fusion
      • acute myeloid leukemia, RUNX1-RUNX1T1 fusion
      • acute myeloid leukemia models, RAS-Scrib-complex-related
    • chronic myeloid leukemia, BCR-ABL1 fusions
    • hematologic cancer, compromised sumoylation
    • hematologic cancer, CUX-related
    • hematologic cancer, Dmel_mxc model
    • HTLV-1-induced adult T-cell leukemia/lymphoma
    • juvenile myelomonocytic leukemia
      • juvenile myelomonocytic leukemia, PTPN11-related
    • myeloproliferative disorders, JAK2-related
  • HPV-related carcinoma, E5-E6-E7-UBE3A models
  • juvenile polyposis syndrome, TGF-beta/BMP signaling pathway
  • Li-Fraumeni syndrome 1
  • lung cancer, adenocarcinoma, KIF5B-RET fusion
  • lung cancer, RAS-PTEN-related
  • multiple endocrine neoplasia
    • multiple endocrine neoplasia, type I
    • multiple endocrine neoplasia, type IIA
    • multiple endocrine neoplasia, type IIB
  • multiple myeloma, DIS3-related
  • myeloproliferative disorders, JAK2-related
  • neuroblastoma, susceptibility to, 3
  • pancreatic carcinoma, multigenic
  • pituitary adenoma 1, multiple types
  • prostate cancer
    • prostate cancer, E-cadherin-related
    • prostate cancer, N-cadherin-related
    • prostate cancer, PAX-related
    • prostate cancer model, Drosophila cell culture exposed to synthetic androgen
    • prostate cancer (postulated), astacin-related
    • prostate cancer (postulated), CNPY1,2-related
    • prostate cancer (postulated), MRGBP-related
  • rhabdoid tumor predisposition syndrome 1
  • rhabdomyosarcoma 2, PAX7-FOXO1 fusion
  • rhabdomyosarcoma 2, PAX3-FOXO1 fusion
  • schwannomatosis, vestibular
  • thyroid carcinoma, familial medullary
    • multiple endocrine neoplasia
  • thyroid carcinoma, nonmedullary
  • von Hippel-Lindau syndrome
• Candida species infection
• cardiac dysfunction (fly models overview)
  • cardiac arrhythmias
    • cardiac arrhythmias and seizure sensitivity, KCNH-related
      • long QT syndrome 2
    • cardiac arrhythmias, KCNQ-related
      • long QT syndrome 1
    • cardiac arrhythmia modeled by tachypacing
    • cardiac arrhythmia (postulated), ATP2A-related
    • cardiac arrhythmia (postulated), CAMK2-related
    • cardiac arrhythmia (postulated), ETNK-related
    • cardiac arrhythmia (postulated), KCNK-related
    • cardiac arrhythmia (postulated), KCNMA1-related
    • long QT syndrome
      • long QT syndrome 1
      • long QT syndrome 2
  • cardiac dysfunction, COX-2 inhibitor-induced
  • cardiac dysfunction, tumor-induced
  • cardiac dysfunction (postulated), CCR4-NOT complex
  • cardiac dysfunction (postulated), CRLS1-related
  • cardiac dysfunction (postulated), PYGO-related
  • cardiac dysfunction (postulated), SOX5-related
  • cardiac dysfunction (postulated), SPARC-related
  • cardiac dysfunction (postulated), talin-related
  • cardiac dysfunction (postulated), TRiC/CCT complex
  • cardiomyopathy
    • arrhythmogenic right ventricular dysplasia 5
    • cardiomyopathy, familial hypertrophic
      • cardiomyopathy, familial hypertrophic 1
      • cardiomyopathy, familial hypertrophic 2
      • cardiomyopathy, familial hypertrophic 3
      • cardiomyopathy, familial hypertrophic 4
      • cardiomyopathy, familial hypertrophic 7
      • cardiomyopathy, familial hypertrophic 10
      • cardiomyopathy, familial hypertrophic 11
      • cardiomyopathy, familial hypertrophic 14
      • cardiomyopathy, familial hypertrophic 15
      • cardiomyopathy, familial hypertrophic 17
      • cardiomyopathy, familial hypertrophic 18
      • cardiomyopathy, familial hypertrophic 26
      • cardiomyopathy, hypertrophic (postulated), EGFR/ERBB-related
      • cardiomyopathy, hypertrophic (postulated), profilin-related
      • cardiomyopathy, hypertrophic (postulated), RAF-related
      • cardiomyopathy, hypertrophic (postulated), RAS-related
    • cardiomyopathy, familial restrictive
      • cardiomyopathy, familial restrictive 1
      • cardiomyopathy, familial restrictive 3
    • cardiomyopathy induced by nephrocyte loss/dysfunction
    • cardiomyopathy, MYBPC3-related
      • cardiomyopathy, familial hypertrophic 4
      • dilated cardiomyopathy 1MM
    • cardiomyopathy, MYH6-MYH7-related
      • cardiomyopathy, familial hypertrophic 1
      • cardiomyopathy, familial hypertrophic 14
      • dilated cardiomyopathy 1EE
      • dilated cardiomyopathy 1S
    • cardiomyopathy, PLN-related
      • cardiomyopathy, familial hypertrophic 18
      • dilated cardiomyopathy 1P
    • cardiomyopathy (postulated), calcineurin-A-related
    • cardiomyopathy (postulated), SOCE-related
    • cardiomyopathy (postulated), translation-critical genes
    • cardiomyopathy, TNNI3-related
      • cardiomyopathy, familial hypertrophic 7
      • cardiomyopathy, familial restrictive 1
      • dilated cardiomyopathy 1FF
      • dilated cardiomyopathy 2A
    • cardiomyopathy, TNNT2-related
      • cardiomyopathy, familial hypertrophic 2
      • cardiomyopathy, familial restrictive 3
      • dilated cardiomyopathy 1D
    • cardiomyopathy, TPM1-related
      • cardiomyopathy, familial hypertrophic 3
    • cardiomyopathy, VCL-related
      • cardiomyopathy, familial hypertrophic 15
      • dilated cardiomyopathy 1W
    • dilated cardiomyopathy
      • dilated cardiomyopathy 1A
      • dilated cardiomyopathy 1D
      • dilated cardiomyopathy 1EE
      • dilated cardiomyopathy 1FF
      • dilated cardiomyopathy 1L
      • dilated cardiomyopathy 1MM
      • dilated cardiomyopathy 1NN
      • dilated cardiomyopathy 1P
      • dilated cardiomyopathy 1S
      • dilated cardiomyopathy 1U
      • dilated cardiomyopathy 1V
      • dilated cardiomyopathy 1W
      • dilated cardiomyopathy 1Y
      • dilated cardiomyopathy 2A
      • dilated cardiomyopathy 2C
      • dilated cardiomyopathy 3B
      • dilated cardiomyopathy, Notch signaling
      • dilated cardiomyopathy, presenilin-related
      • dilated cardiomyopathy (postulated), CNOT3-related
      • dilated cardiomyopathy (postulated), rhomboid-EGFR signaling
    • high-fat diet, cardiomyopathy
    • high-sugar diet, cardiomyopathy
    • lipotoxic cardiomyopathy, ceramide/sphingolipid-related
    • muscle and aortic defects, ARIH1-related
• cardiac function, response to hypoxia
• cardiofaciocutaneous syndrome
  • cardiofaciocutaneous syndrome 3
  • cardiofaciocutaneous syndrome 4
• cataract 48, infantile-onset
• CEDNIK syndrome
• centronuclear myopathy
  • centronuclear myopathy 1
  • centronuclear myopathy 2
  • centronuclear myopathy, X-linked
• cerebellar atrophy, visual impairment, and psychomotor retardation
• cerebral amyloid angiopathy
  • cerebral amyloid angiopathy, APP-related
  • cerebral amyloid angiopathy, ITM2B-related
    • cerebral amyloid angiopathy, ITM2B-related, 1
    • cerebral amyloid angiopathy, ITM2B-related, 2
• cerebral cavernous malformations 3
• cerebral palsy, spastic quadriplegic
  • cerebral palsy, spastic quadriplegic, 3
• Charcot-Marie-Tooth disease
  • Charcot-Marie-Tooth disease, axonal, type 2EE
  • Charcot-Marie-Tooth disease, axonal, type 2L
  • Charcot-Marie-Tooth disease, dominant intermediate B
  • Charcot-Marie-Tooth disease, dominant intermediate C
  • Charcot-Marie-Tooth disease, dominant intermediate E
  • Charcot-Marie-Tooth disease, GDAP1-related
    • Charcot-Marie-Tooth disease, axonal, with vocal cord paresis
    • Charcot-Marie-Tooth disease, recessive intermediate A
    • Charcot-Marie-Tooth disease, type 2K
    • Charcot-Marie-Tooth disease, type 4A
  • Charcot-Marie-Tooth disease, MFN2-related
    • Charcot-Marie-Tooth disease, axonal, type 2A2A
    • Charcot-Marie-Tooth disease, axonal, type 2A2B
    • neuropathy, hereditary motor and sensory, type VIA
  • Charcot-Marie-Tooth disease, RAB40B-related
  • Charcot-Marie-Tooth disease, recessive intermediate D
  • Charcot-Marie-Tooth disease, type 2B
  • Charcot-Marie-Tooth disease, type 2D
  • Charcot-Marie-Tooth disease, type 2T
  • Charcot-Marie-Tooth disease, type 4B1
  • Charcot-Marie-Tooth disease, type 4J
  • Charcot-Marie-Tooth disease (postulated), SGPL1-related
  • neuropathy, hereditary motor and sensory, type IIC
• CHARGE syndrome, CHD7-related
• Chediak-Higashi syndrome
• chorea-acanthocytosis
• chromosome 3q29 deletion syndrome
• chromosome 15q11.2 deletion syndrome
• chromosome 16p11.2 deletion syndrome, 593-kb
• chromosome 22q11.2 deletion syndrome
• chronic inflammatory lung disease
• chronic myeloid leukemia, BCR-ABL1 fusions
• ciliary dyskinesia, primary
  • ciliary dyskinesia, primary, 9, with or without situs inversus
  • ciliary dyskinesia, primary, 18
  • ciliary dyskinesia, primary, 22
• CODAS syndrome
• coenzyme Q10 deficiency, primary
  • coenzyme Q10 deficiency, primary, 4
  • nephrotic syndrome related to coenzyme Q deficiency
• Coffin-Lowry syndrome
• Coffin-Siris syndrome
  • Coffin-Siris syndrome, ARID1A,1B-related
    • Coffin-Siris syndrome 1
    • Coffin-Siris syndrome 2
      
  • Coffin-Siris syndrome 3
  • Coffin-Siris syndrome 4
  • Coffin-Siris syndrome 8
  • Coffin-Siris syndrome 11
  • Coffin-Siris syndrome 12
  • Coffin-Siris syndrome (postulated), PHF10-related
• cognitive/behavioral disorders, PRODH-related
• cognitive disorders, diet-induced
• cognitive impairment, drug-induced
• colorectal cancer
  • cancer, intestinal dysplasia, UVRAG-related
  • cancer, intestinal stem cell, SRC-related
  • colorectal cancer, multigenic
  • colorectal cancer, multigenic, personalized
  • colorectal cancer, personalizable in silico model
  • familial adenomatous polyposis
• combined D-2- and L-2-hydroxyglutaric aciduria
• combined oxidative phosphorylation deficiency
  • combined oxidative phosphorylation deficiency 1
  • combined oxidative phosphorylation deficiency 14
  • combined oxidative phosphorylation deficiency 17
  • combined oxidative phosphorylation deficiency 28
  • combined oxidative phosphorylation deficiency 30
  • combined oxidative phosphorylation deficiency 54
• cone-rod dystrophy
  • cone-rod dystrophy 2
  • cone-rod dystrophy 12
• congenital disorders of glycosylation, type I
  • congenital disorder of glycosylation, type Ia
  • congenital disorder of glycosylation, type Ij
• congenital disorders of glycosylation, type II
  • congenital disorder of glycosylation, type IIc
  • congenital disorder of glycosylation, type IIe
  • congenital disorder of glycosylation, type IIr
• congenital heart defect
  • atrial septal defect
    • atrial septal defect 4
  • congenital heart defect (postulated), CHD7-related
  • congenital heart defect (postulated), EIF4G3-related
  • congenital heart defect (postulated), KMT2-related
  • congenital heart defect (postulated), LRP2-related
  • congenital heart defect (postulated), METTL23-related
  • congenital heart defect (postulated), PSMD7-related
  • congenital heart defect (postulated), RPL13-related
  • congenital heart defect (postulated), RPL14-related
  • congenital heart defect (postulated), RPS24-related
  • congenital heart defect (postulated), SREBF1-related
  • congenital heart defect (postulated), UBB-related
  • congenital heart defect (postulated), UBE2B-related
  • congenital heart defect (postulated), WDR5-related
  • congenital heart defect (postulated), KIF1A-related
  • hypoplastic left heart syndrome (postulated), CHCHD3,6-related
• congenital myasthenic syndrome
  • congenital myasthenic syndrome 7, presynaptic
• copper metabolism disorders, ATP7-related
  • Menkes disease
  • neuronopathy, distal hereditary motor, X-linked
  • occipital horn syndrome
  • Wilson disease
• copper metabolism disorder (postulated), SLC31A-related
• Cornelia de Lange syndrome
  • Cornelia de Lange syndrome 1
• Costello syndrome
• Cowden syndrome 1
• Creutzfeldt-Jakob disease, familial
• cystic fibrosis, gastrointestinal pathologies
• cystic fibrosis-like, miRNA-mediated ENaC dysregulation
• cystic renal dysplasia, susceptibility to, BICC1-related
• D-2-hydroxyglutaric aciduria
  • D-2-hydroxyglutaric aciduria 2
  • combined D-2- and L-2-hydroxyglutaric aciduria
• Darier-White disease
• deafness and hearing loss (fly models overview)
  • auditory neuropathy, autosomal dominant 1
  • branchiootorenal spectrum disorders, EYA1-related
    • branchiootic syndrome 1
  • ciliary dyskinesia, primary
  • deafness, autosomal dominant
    • deafness, autosomal dominant 11
  • deafness, autosomal recessive
    • deafness, autosomal recessive 2
    • deafness, autosomal recessive 36
    • deafness, autosomal recessive 67
    • deafness, autosomal recessive 114
  • DOORS syndrome
  • mitochondrial disease with seizure-sensitivity and hearing loss (postulated), MRPS12-related
  • noise-induced hearing loss
  • Siddiqi syndrome
  • Usher syndrome
    • Usher syndrome, type I
    • Usher syndrome, type IJ
  • Usher syndrome, deafness, MYO7A-related
• dentatorubral-pallidoluysian atrophy
• depression-like behaviors, drug-induced
• depression-like behaviors, stress-induced
• depression-like behaviors (postulated), MIR184-related
• DeSanto-Shinawi syndrome
• developmental and epileptic encephalopathy
  • developmental and epileptic encephalopathy 6
  • developmental and epileptic encephalopathy 11
  • developmental and epileptic encephalopathy 13
  • developmental and epileptic encephalopathy 14
  • developmental and epileptic encephalopathy 17
  • developmental and epileptic encephalopathy 25, with amelogenesis imperfecta
  • developmental and epileptic encephalopathy 34
  • developmental and epileptic encephalopathy 44
  • developmental and epileptic encephalopathy 47
  • developmental and epileptic encephalopathy 57
  • developmental and epileptic encephalopathy 64
  • developmental and epileptic encephalopathy 87
  • developmental and epileptic encephalopathy 96
  • developmental and epileptic encephalopathy 109
  • developmental and epileptic encephalopathy (postulated), ROBO1-related
  • developmental and epileptic encephalopathy (postulated), TMEM63B-related
• developmental delay and seizures, FARS2-related
  • combined oxidative phosphorylation deficiency 14
  • spastic paraplegia 77
• developmental delay, dysmorphic facies, and brain anomalies
• diabetes mellitus, insulin-dependent (type 1) (fly models overview)
  • diabetes mellitus type 1, environmental toxin-induced
  • diabetes mellitus type 1, insulin peptide deficiency
  • diabetes mellitus, insulin-dependent, IPC-ablation models
  • diabetes mellitus, insulin-dependent, IPC-blocking model
  • diabetes mellitus, permanent neonatal 4
  • obesity and diabetes type 1, susceptibility to (postulated), ITPR-related
• diabetes mellitus, insulin-resistant, with acanthosis nigricans
• diabetes mellitus, noninsulin-dependent (type 2) (fly models overview)
  • diabetes mellitus type 2, environmental toxin-induced
  • diabetes mellitus type 2, susceptibility to, AKT-related
  • diabetes mellitus type 2, susceptibility to, HHEX-related
  • diabetes mellitus type 2, susceptibility to, IGF2BP-related
  • diabetes mellitus type 2, susceptibility to, IRS1,2-related
  • diabetes mellitus type 2, susceptibility to (postulated), AFF2-related
  • diabetes mellitus type 2, susceptibility to (postulated), BCL11A-related
  • diabetes mellitus type 2, susceptibility to (postulated), GLIS3-related
  • diabetes mellitus type 2, susceptibility to (postulated), UCHL1-related
  • diabetes/obesity, impact of parental disease
  • glucose metabolism disease, GCK-related
    • maturity-onset diabetes of the young, type 2
  • high-fat diet, insulin pathway effects
  • high-protein diet, insulin pathway effects
  • high-sugar diet, adipokinetic hormone signaling
  • high-sugar diet, insulin pathway effects
  • insulin pathway effects, BMP/TGFB-related
  • insulin pathway effects, decretin-related
  • insulin pathway effects, DGK-related
  • insulin pathway effects, FMR1-related
  • insulin pathway effects, IDE-related
  • insulin pathway effects, mechanical stress requirement
  • insulin pathway effects, MIR137/PTPN1,2-related
  • insulin pathway effects, MYORG-related
  • insulin pathway effects, NUDT-related
  • insulin pathway effects, PIK3C-related
  • insulin pathway effects, RHEB-related
  • insulin pathway effects, RPS6KB-related
  • insulin pathway effects, SIRT1-related
  • insulin pathway effects, TMEM18-related
  • insulin pathway effects, TRIB-related
  • insulin resistance syndromes, INSR-related
    • diabetes mellitus, insulin-resistant, with acanthosis nigricans
    • Donohue syndrome
    • pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
  • insulin signaling, regulation of fat storage, Drosophila fat body model
  • maturity-onset diabetes of the young, type 1
• diabetes mellitus, pathogenic impact, glyoxalase function
• diabetes/obesity, impact of parental disease
• diabetic neuropathy
• Donohue syndrome
• DOORS syndrome
• Down syndrome
  • Down syndrome, DSCAM-related
  • Down syndrome, DYRK1A-related
  • Down syndrome, ITSN1-SYNJ1-RCAN1-related
  • Down syndrome, RCAN1-related
  • Down syndrome heart defects, DSCAM-COL6A2-related
• drug discovery and assessment (fly models overview)
• Duchenne muscular dystrophy
• DYRK1A-related intellectual disability syndrome
• dyskeratosis congenita
  • dyskeratosis congenita, X-linked
• dyskinesia, drug-induced
• dystonia
  • dystonia 1
  • dystonia, early-onset, and/or spastic paraplegia
  • MEPAN syndrome
• Ehlers-Danlos syndrome
  • Ehlers-Danlos syndrome, spondylodysplastic type 1
  • Ehlers-Danlos syndrome, spondylodysplastic type 3
• encephalopathy due to defective mitochondrial and peroxisomal fission 1
• encephalopathy, familial, with neuroserpin inclusion bodies
• encephalopathy, hypotonia and developmental delay, OXA1L-related
• encephalopathy, neonatal severe, MECP2-related
• encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum
• epidermolysis bullosa simplex, keratin-related
  • epidermolysis bullosa simplex, localized
  • epidermolysis bullosa simplex, generalized
  • epidermolysis bullosa simplex, generalized severe
• epilepsy
  • developmental and epileptic encephalopathy
    • developmental and epileptic encephalopathy 6
    • developmental and epileptic encephalopathy 11
    • developmental and epileptic encephalopathy 13
    • developmental and epileptic encephalopathy 14
    • developmental and epileptic encephalopathy 25, with amelogenesis imperfecta
    • developmental and epileptic encephalopathy 34
    • developmental and epileptic encephalopathy 57
    • developmental and epileptic encephalopathy 64
    • developmental and epileptic encephalopathy 87
    • developmental and epileptic encephalopathy 96
  • epilepsy, chemically-induced
  • epilepsy, early-onset
    • epilepsy, early-onset, 3, with or without developmental delay
  • epilepsy, familial adult myoclonic
    • epilepsy, familial adult myoclonic, 4
  • epilepsy, focal (postulated), UNC13B-related
  • epilepsy, generalized, with febrile seizures plus
    • epilepsy, generalized, with febrile seizures plus, type 2
    • epilepsy, generalized, with febrile seizures plus, type 7
  • epilepsy, nocturnal frontal lobe, 5
  • epilepsy, photosensitive, sphingolipid/sphingomyelin-related
  • epilepsy, PRICKLE-related
    • epilepsy, progressive myoclonic 1B
  • epilepsy, progressive myoclonic
    • epilepsy, progressive myoclonic 1B
    • epilepsy, progressive myoclonic 6
  • epilepsy, refractory, SCN-alpha-ABCC1 model
  • epilepsy, rolandic, with paroxysmal exercise-induced dystonia
  • epilepsy, SCN-alpha-related
    • developmental and epileptic encephalopathy, 6
    • developmental and epileptic encephalopathy, 11
    • developmental and epileptic encephalopathy, 13
    • epilepsy, generalized, with febrile seizures plus, type 2
    • epilepsy, generalized, with febrile seizures plus, type 7
    • seizures, benign familial infantile, 3
  • epilepsy, SLC12A5-related
    • developmental and epileptic encephalopathy, 34
    • epilepsy, idiopathic generalized, susceptibility to, 14
  • Kohlschutter-Tonz syndrome
  • mitochondrial disease with seizure-sensitivity and hearing loss (postulated), MRPS12-related
  • myoclonic-atonic epilepsy
  • seizures, benign familial infantile
    • seizures, benign familial infantile, 3
  • seizure-sensitive (postulated), ETNK-related
  • seizure-sensitive (postulated), SLC12A1-3-related
  • seizure-sensitive (postulated), SLC24A-related
  • seizure-sensitive, potassium channel defects (eag, Sh model)
  • seizure-sensitive, potassium channel defects, KCNT1-2-related
    • developmental and epileptic encephalopathy 14
    • developmental and epileptic encephalopathy 57
    • epilepsy, nocturnal frontal lobe, 5
  • seizure sensitive/resistant (postulated), PRKG1-related
  • seizure sensitivity, disruption during critical developmental period
  • seizure-sensitivity model, Dmel_jus
• episodic ataxia
  • episodic ataxia, type 1
  • episodic ataxia, type 6
• Epstein-Barr virus infection
• erythrokeratodermia variabilis et progressiva 1
• Escherichia coli infection
• essential tremor, hereditary
  • essential tremor, hereditary, 4
  • essential tremor (postulated), KCNS2-related
• Ewing sarcoma
• Fabry disease
• familial adenomatous polyposis
  • familial adenomatous polyposis 1
• Fanconi anemia
  • Fanconi anemia, complementation group D2
  • Fanconi anemia, complementation group L
• Fanconi renotubular syndrome 4 with MODY
• fascioscapulohumeral muscular dystrophy, DUX4-related
• fascioscapulohumeral muscular dystrophy, FRG1-related
• fatal familial insomnia
• fibrodysplasia ossificans progressiva
• fibrosis, pericellular accumulation of collagen IV
• flavivirus infection (dengue, West Nile, Zika)
• Fliedner-Zweier syndrome
• focal segmental glomerulosclerosis
  • focal segmental glomerulosclerosis 1
  • focal segmental glomerulosclerosis 3
  • focal segmental glomerulosclerosis 4, susceptibility to
  • focal segmental glomerulosclerosis 5
• fragile-X-related syndromes
  • fragile X syndrome
  • fragile X tremor/ataxia syndrome
• Friedreich ataxia 1
• frontotemporal dementia
  • frontotemporal dementia with parkinsonism 17
• frontotemporal dementia and/or amyotrophic lateral sclerosis 1
• frontotemporal dementia and/or amyotrophic lateral sclerosis 2
• frontotemporal dementia and/or amyotrophic lateral sclerosis 3
• frontotemporal dementia and/or amyotrophic lateral sclerosis 4
• frontotemporal dementia and/or amyotrophic lateral sclerosis 6
• frontotemporal dementia and/or amyotrophic lateral sclerosis 7
• frontotemporal dementia and/or amyotrophic lateral sclerosis, TAF15-related
• galactosemia
  • galactose epimerase deficiency
  • galactosemia, classic
• Galloway-Mowat syndrome 3
• GAND syndrome
• gastric cancer, hereditary diffuse, CDH1-related
• gastric cancer, TPM4-ALK fusion
• Gaucher disease, GBA1-related
• genotoxicity studies (fly models overview)
• geroderma osteodysplastica
• Gerstmann-Straussler disease
• glaucoma
  • glaucoma 1A, open angle, early-onset
  • glaucoma 1E, primary open angle
• global developmental delay and congenital ataxia, CACNA1A-related
• global developmental delay with impaired intellectual development, hypotonia, and seizures, CAPZA2-related
• glucose metabolism disease, GCK-related
  • maturity-onset diabetes of the young, type 2
• glycerol kinase deficiency
• glycogen accumulation disorders, GYS1 model
• glycogen storage disease III
• Harel-Yoon syndrome
• Halperin-Birk syndrome
• hematologic cancer (fly models overview)
  • acute myeloid leukemia
    • acute myeloid leukemia, MLF1-related
    • acute myeloid leukemia, MLL-AF fusions
    • acute myeloid leukemia, NUP98-HOXA9 fusion
    • acute myeloid leukemia, RUNX1-RUNX1T1 fusion
    • acute myeloid leukemia models, RAS-Scrib-complex-related
  • chronic myeloid leukemia, BCR-ABL1 fusions
  • hematologic cancer, compromised sumoylation
  • hematologic cancer, CUX-related
  • hematologic cancer, Dmel_mxc model
  • HTLV-1-induced adult T-cell leukemia/lymphoma
  • juvenile myelomonocytic leukemia
    • juvenile myelomonocytic leukemia, PTPN11-related
  • myeloproliferative disorders, JAK2-related
• Hengel-Maroofian-Schols syndrome
• Hennekam lymphangiectasia-lymphedema syndrome 2
• Hermansky-Pudlak syndrome
  • Hermansky-Pudlak syndrome 2
  • Hermansky-Pudlak syndrome 4
  • Hermansky-Pudlak syndrome 5
  • Hermansky-Pudlak syndrome 7
  • Hermansky-Pudlak syndrome 9
  • Hermansky-Pudlak syndrome (postulated), BLOC1S1-related
• high-fat diet, cardiomyopathy
• high-fat diet, insulin pathway effects
• high-fat diet, kidney disease
• high-fat diet, obesity
• high-protein diet, insulin pathway effects
• high-salt diet, locomotor and cardiac dysfunction
• high-starch diet, obesity
• high-sugar diet, adipokinetic hormone signaling
• high-sugar diet, cardiomyopathy
• high-sugar diet, insulin pathway effects
• high-sugar diet, nephropathy
• high-sugar diet, obesity
• high-sugar diet, retinopathy
• Hirschsprung disease, susceptibility to, 1
• histiocytosis-lymphadenopathy plus syndrome
• HIV infection
• homocystinuria due to cystathionine beta-synthase deficiency
• HPV-related carcinoma, E5-E6-E7-UBE3A models
• HSD10 mitochondrial disease
• HTLV-1-induced adult T-cell leukemia/lymphoma
• Huntington disease
• Huntington disease-like 2
• Hutchinson-Gilford progeria syndrome
• hydrolethalus syndrome 1
• hyperoxaluria, primary
  • hyperoxaluria, primary, type 1
• hyperprolinemia, type II
• hypoparathyroidism, familial isolated, GCM2-related
• hypoparathyroidism-retardation-dysmorphism syndrome
• hypoplastic left heart syndrome (postulated), CHCHD3,6-related
• hypotonia, ataxia, and delayed development syndrome
• hypoxia adaptation and chronic mountain sickness
• ichthyosis, Dmel_osy model
• IMAGe syndrome
• immune and hematological syndromes, CDC42-related
• inclusion body myopathy with Paget disease of bone and frontotemporal dementia
  • inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
  • inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2
  • inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3
  • inclusion body myopathy with or without frontotemporal dementia (postulated), SVIP-related
• infantile cerebellar-retinal degeneration
• infection by eukaryotic pathogens
  • Aspergillus species infection
  • Candida species infection
  • Leishmania species infection
• infection by prokaryotic pathogens
  • Escherichia coli infection
  • Listeria monocytogenes infection
  • Mycobacterium species infection
  • Pseudomonas aeruginosa infection
  • Salmonella species infection
  • Serratia marcescens infection
  • Staphylococcus aureus infection
  • Streptococcus species infection
  • Vibrio cholerae infection
• infection by viral pathogens
  • Epstein-Barr virus infection
  • flavivirus infection (dengue, West Nile, Zika)
  • HIV infection
  • SARS-CoV-1,2 viral infection
  • Sindbis virus infection
  • viral infection, susceptibility to (postulated), EHMT-related
• inflammatory bowel disease
  • inflammatory bowel disease 10, susceptibility to
• inflammatory bowel disease, tight/septate junction defect
• insulin pathway effects, BMP/TGFB-related
• insulin pathway effects, decretin-related
• insulin pathway effects, FMR1-related
• insulin pathway effects, IDE-related
• insulin pathway effects, MIR137/PTPN1,2-related
• insulin pathway effects, MYORG-related
• insulin pathway effects, NUDT-related
• insulin pathway effects, PIK3C-related
• insulin pathway effects, RHEB-related
• insulin pathway effects, RPS6KB-related
• insulin pathway effects, SIRT1-related
• insulin pathway effects, TMEM18-related
• insulin pathway effects, TRIB-related
• insulin resistance syndromes, INSR-related
  • diabetes mellitus, insulin-resistant, with acanthosis nigricans
  • Donohue syndrome
  • pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
• intellectual developmental disorder with abnormal behavior, microcephaly, and short stature
• intellectual developmental disorder with ocular anomalies and distinctive facial features
• intellectual developmental disorder with short stature and behavioral abnormalities, IQSEC1-related
• intellectual developmental disorder, X-linked, syndromic, Pilorge type
• intellectual developmental disorders, SMARCA2,4-related
  • Coffin-Siris syndrome 4
  • Nicolaides-Baraitser syndrome
• intellectual disability, autosomal dominant
  • Coffin-Siris syndrome
    • Coffin-Siris syndrome, ARID1A,1B-related
      • Coffin-Siris syndrome 1
      • Coffin-Siris syndrome 2
        
    • Coffin-Siris syndrome 3
    • Coffin-Siris syndrome 4
    • Coffin-Siris syndrome 8
    • Coffin-Siris syndrome 11
    • Coffin-Siris syndrome 12
    • Coffin-Siris syndrome (postulated), PHF10-related
  • DYRK1A-related intellectual disability syndrome
  • GAND syndrome
  • intellectual developmental disorders, SMARCA2,4-related
  • intellectual disability, autosomal dominant 21
  • intellectual disability, autosomal dominant 34
  • intellectual disability, autosomal dominant 48
  • intellectual disability, autosomal dominant, CAMK2-related
    • intellectual disability, autosomal dominant 53
    • intellectual disability, autosomal dominant 54
  • intellectual disability, syndromic, autosomal dominant, ZMYND8-related
  • Kleefstra syndrome 1
  • Koolen-De Vries syndrome
  • Luo-Schoch-Yamamoto syndrome
  • NESCAV syndrome
• intellectual disability, autosomal recessive
  • intellectual disability, autosomal recessive 2
  • intellectual disability, autosomal recessive 5
  • intellectual disability, autosomal recessive 37
  • intellectual disability, autosomal recessive 46
  • intellectual disability, autosomal recessive 56
  • intellectual disability, autosomal recessive 65
  • intellectual disability, syndromic, with renal and cardiac dysfunction, ADD3-KAT2B-related
• intellectual disability, BRWD-related
• intellectual disability, KDM5-related
  • intellectual disability, autosomal recessive 65
  • intellectual disability, X-linked, syndromic, Claes-Jensen type
• intellectual disability, syndromic, autosomal dominant, ZMYND8-related
• intellectual disability, syndromic, PPFIA3-related
• intellectual disability with brain malformation, autosomal dominant, YWHAZ-related
• intellectual disability, X-linked, nonsyndromic
  • intellectual disability, X-linked 9
  • intellectual disability, X-linked 63
  • intellectual disability, X-linked 106
• intellectual disability, X-linked, syndromic
  • fragile X syndrome
  • intellectual disability, X-linked, CASK-related
    • intellectual disability, X-linked, MICPCH syndrome
    • intellectual disability, X-linked, FG syndrome 4
  • intellectual disability, X-linked, syndromic 13
  • intellectual disability, X-linked, syndromic 34
  • intellectual disability, X-linked, syndromic, Claes-Jensen type
  • intellectual disability, X-linked, syndromic, Hedera type
  • intellectual disability, X-linked, syndromic, Lubs type
  • intellectual disability, X-linked, syndromic, Nascimento type
  • intellectual disability, X-linked, syndromic, Snyder-Robinson type
  • intellectual disability, X-linked, syndromic, Turner type
  • intellectual disability, X-linked, with cerebellar hypoplasia and distinctive facial appearance
  • Renpenning syndrome 1
• intellectual disability (postulated), BOD1-related
• intellectual disability (postulated), GPM6A-related
• intestinal dysfunction, RET-related
  • Hirschsprung disease, susceptibility to, 1
• intrauterine growth restriction, symmetrical, insulin-signaling-related
• juvenile myelomonocytic leukemia
  • juvenile myelomonocytic leukemia, PTPN11-related
• juvenile polyposis syndrome, TGF-beta/BMP signaling pathway
• kidney disease (fly models overview)
  • branchiootorenal spectrum disorders, EYA1-related
    • branchiootorenal syndrome 1
    • branchiootic syndrome 1
  • cystic renal dysplasia, susceptibility to, BICC1-related
  • focal segmental glomerulosclerosis
    • focal segmental glomerulosclerosis 1
    • focal segmental glomerulosclerosis 3
    • focal segmental glomerulosclerosis 4, susceptibility to
    • focal segmental glomerulosclerosis 5
  • Galloway-Mowat syndrome 3
  • high-fat diet, kidney disease
  • high-sugar diet, nephropathy
  • intellectual disability, syndromic, with renal and cardiac dysfunction, ADD3-KAT2B-related
  • kidney disease, PAN-induced
  • kidney disease (postulated), AMN-related
  • kidney disease (postulated), CDC42-related
  • kidney disease (postulated), CUBN-related
  • kidney disease (postulated), NFATC1-related
  • kidney disease (postulated), PALS1-related
  • kidney disease (postulated), RGS14-related
  • kidney disease (postulated), SRC-kinase-related
  • kidney stone disease, chemically-induced
  • kidney stone disease, V-ATPase models
  • nephrotic syndrome
    • nephrotic syndrome, KANK-related
      • nephrotic syndrome, type 16
    • nephrotic syndrome, KIRREL-related
      • nephrotic syndrome, type 23
    • nephrotic syndrome, type 1
    • nephrotic syndrome, type 2
    • nephrotic syndrome, type 9
    • nephrotic syndrome, type 12
    • nephrotic syndrome, type 14
    • nephrotic syndrome, type 19
    • nephrotic syndrome, type 20
    • nephrotic syndrome, type 23
    • nephrotic syndrome related to coenzyme Q deficiency
    • nephrotic syndrome (postulated), GAPVD1-related
    • nephrotic syndrome (postulated), stomatin-related
  • polycystic kidney disease
    • polycystic kidney disease 2
  • renal fibrosis, steroid-induced
  • xanthinuria, type I
• Kleefstra syndrome
  • Kleefstra syndrome 1
  • Kleefstra syndrome 2
• Kohlschutter-Tonz syndrome
• Koolen-De Vries syndrome
• Kufor-Rakeb syndrome (PARK9)
• L1 syndrome
• laminopathies
  • dilated cardiomyopathy 1A
  • Hutchinson-Gilford progeria syndrome
  • muscular dystrophy, lamin-related
    • muscular dystrophy, congenital, LMNA-related
    • Emery-Dreifuss muscular dystrophy 2
    • Emery-Dreifuss muscular dystrophy 3
• Leber congenital amaurosis
  • Leber congenital amaurosis 7
  • Leber congenital amaurosis 8
  • Leber congenital amaurosis (postulated), PNPLA6-related
• Leber hereditary optic neuropathy
  • Leber hereditary optic neuropathy, MT-ND2-related
• Leigh syndrome
  • Leigh syndrome, MT-ATP6-related
  • Leigh syndrome, MT-ND2-related
• Leishmania species infection
• leptin deficiency or dysfunction
• leukodystrophy, hypomyelinating
  • leukodystrophy, hypomyelinating, 5
  • leukodystrophy, hypomyelinating, 18
  • leukodystrophy, hypomyelinating, 23, with ataxia, deafness, liver dysfunction, and dilated cardiomyopathy
• leukodystrophy, demyelinating, adult-onset, autosomal dominant
• leukodystrophy with ataxia and sensorineural deafness
• Lewy body dementia, SNCA-related
• Lewy body dementia, susceptibility to, GBA1-related
• Li-Fraumeni syndrome 1
• lipodystrophy, congenital generalized
  • lipodystrophy, congenital generalized, type 2
• lipodystrophy, familial partial
  • lipodystrophy, familial partial, type 2
• lipotoxic cardiomyopathy, ceramide/sphingolipid-related
• lissencephaly
  • lissencephaly 6 with microcephaly
  • lissencephaly 8
• Listeria monocytogenes infection
• liver disease (fly models overview)
  • metabolic dysfunction-associated steatotic liver disease
• long QT syndrome
  • long QT syndrome 1
  • long QT syndrome 2
• long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
• Lowe oculocerebrorenal syndrome
• lung cancer, adenocarcinoma, KIF5B-RET fusion
• lung cancer, RAS-PTEN-related
• Luo-Schoch-Yamamoto syndrome
• lysosomal storage disorder (postulated), SPNS-related
• Machado-Joseph disease (SCA3)
• macrocephaly-autism syndrome
• macular retinal dystrophy, North Carolina type, PRDM13-related
• maple syrup urine disease, type II
• maturity-onset diabetes of the young
  • Fanconi renotubular syndrome 4 with MODY
  • maturity-onset diabetes of the young, type 1
  • maturity-onset diabetes of the young, type 2
• megaloblastic anemia 1
• Meier-Gorlin syndrome
  • Meier-Gorlin syndrome 2
  • Meier-Gorlin syndrome 3
• Menkes disease
• MEPAN syndrome
• metabolic dysfunction-associated steatotic liver disease
• microcephalic primordial dwarfism
  • Meier-Gorlin syndrome
    • Meier-Gorlin syndrome 2
    • Meier-Gorlin syndrome 3
  • microcephalic dwarfism syndromes, DONSON-related
    • microcephaly, short stature, and limb abnormalities
• microcephaly, primary
  • microcephaly 1, primary, autosomal recessive
  • microcephaly 2, primary, autosomal recessive
  • microcephaly 5, primary, autosomal recessive
  • microcephaly 16, primary, autosomal recessive
  • microcephaly 17, primary, autosomal recessive
  • microcephaly 18, primary, autosomal dominant
  • microcephaly, centrosome-SAC dysfunction
    • microcephaly 3, primary, autosomal recessive
    • microcephaly 6, primary, autosomal recessive
  • pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures
• microcephaly, Zika virus-related
• migraine, familial hemiplegic 1
• migraine, familial hemiplegic 2
• Mitchell syndrome
• mitochondrial complex I deficiency, nuclear type
  • mitochondrial complex I deficiency, nuclear type 1
  • mitochondrial complex I deficiency, nuclear type 2
  • mitochondrial complex I deficiency, nuclear type 3
    
  • mitochondrial complex I deficiency, nuclear type 4
  • mitochondrial complex I deficiency, nuclear type 5
  • mitochondrial complex I deficiency, nuclear type 11
  • mitochondrial complex I deficiency, nuclear type 17
  • mitochondrial complex I deficiency, nuclear type 18
  • mitochondrial complex I deficiency, nuclear type 22
• mitochondrial complex I disorders, MT-ND2-related
  • Leber hereditary optic neuropathy, MT-ND2-related
  • Leigh syndrome, MT-ND2-related
• mitochondrial complex II deficiency, nuclear type
  • mitochondrial complex II deficiency, nuclear type 1
  • mitochondrial complex II deficiency, nuclear type 4
• mitochondrial complex II deficiency (postulated), SDHAF4-related
• mitochondrial complex III deficiency, nuclear type
  • mitochondrial complex III deficiency, nuclear type 1
  • mitochondrial complex III deficiency, nuclear type 2
• mitochondrial complex IV deficiency, nuclear type
  • mitochondrial complex IV deficiency, nuclear type 1
  • mitochondrial complex IV deficiency, nuclear type, SCO1,2-related
    • mitochondrial complex IV deficiency, nuclear type 2
    • mitochondrial complex IV deficiency, nuclear type 4
  • mitochondrial complex IV deficiency, nuclear type 5
  • mitochondrial complex IV deficiency, nuclear type 17
  • mitochondrial complex IV disorder (postulated), CEP89-related
  • mitochondrial complex IV dysfunction, general model
  • spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3
• mitochondrial complex IV disorders, MT-CO1-related
• mitochondrial complex V (ATP synthase) deficiency, nuclear type
  • mitochondrial complex V (ATP synthase) deficiency, nuclear type, ATP5MC model
  • mitochondrial complex V (ATP synthase) deficiency, nuclear type 5
• mitochondrial complex V disorders, MT-ATP6-related
  • Leigh syndrome, MT-ATP6-related
  • myopathy, lactic acidosis, and sideroblastic anemia 3
  • neuropathy, ataxia, and retinitis pigmentosa
  • striatonigral degeneration, infantile, mitochondrial
• mitochondrial disease with seizure-sensitivity and hearing loss (postulated), MRPS12-related
• mitochondrial disease and seizure sensitivity, SLC25A4(ANT1)-related
  • mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant
  • mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive
  • progressive external ophthalmoplegia with mtDNA deletions, autosomal dominant 2
• mitochondrial disorders, VDAC-related
• mitochondrial DNA depletion syndrome
  • Alpers-Huttenlocher syndrome
  • mitochondrial DNA depletion syndrome 4B (MNGIE type)
  • mitochondrial DNA depletion syndrome 6 (hepatocerebral type)
  • mitochondrial DNA depletion syndrome 9
  • mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant
  • mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive
  • mitochondrial DNA depletion syndrome 17
• mitochondrial pyruvate carrier deficiency
• mitochondrial respiratory complex disease, mitochondrial types
• mitochondrial trifunctional protein deficiency
  • mitochondrial trifunctional protein deficiency, HADHA-related
  • mitochondrial trifunctional protein deficiency, HADHB-related
• motor neuron disease (postulated), WRAP53-related
• motor neuron disease (postulated), VPS54-related
• mtDNA polymerase disorders, POLG-related
  • Alpers-Huttenlocher syndrome
  • mitochondrial DNA depletion syndrome 4B (MNGIE type)
  • progressive external ophthalmoplegia with mtDNA deletions, autosomal dominant 1
  • progressive external ophthalmoplegia with mtDNA deletions, autosomal recessive 1
  • sensory ataxic neuropathy, dysarthria, and ophthalmoparesis
• mucolipidosis IV
• mucopolysaccharidoses
  • mucopolysaccharidosis type I
  • mucopolysaccharidosis type IIIA
  • mucopolysaccharidosis type IIIB
  • mucopolysaccharidosis type IIIC
  • mucopolysaccharidosis type VII
• multiple acyl-CoA dehydrogenase deficiency
  • multiple acyl-CoA dehydrogenase deficiency, ETFDH-related
• multiple endocrine neoplasia
  • multiple endocrine neoplasia, type I
  • multiple endocrine neoplasia, type IIA
  • multiple endocrine neoplasia, type IIB
• multiple myeloma, DIS3-related
• multiple sulfatase deficiency
• multisystemic disorder with developmental delay, skeletal, cardiac, and neurological abnormalities, TMEM208-related
• muscle and aortic defects, ARIH1-related
• muscular dystrophy
  • fascioscapulohumeral muscular dystrophy, DUX4-related
  • fascioscapulohumeral muscular dystrophy, FRG1-related
  • muscular dystrophy, DAG1-related
    • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9
    • muscular dystrophy-dystroglycanopathy (limb-girdle), type C9
  • muscular dystrophy, dystrophin-related
    • Becker muscular dystrophy
    • Duchenne muscular dystrophy
  • muscular dystrophy, Emery-Dreifuss
    • Emery-Dreifuss muscular dystrophy 2
    • Emery-Dreifuss muscular dystrophy 3
    • Emery-Dreifuss muscular dystrophy, LINC-complex-related
  • muscular dystrophy, lamin-related
    • Emery-Dreifuss muscular dystrophy 2
    • Emery-Dreifuss muscular dystrophy 3
    • muscular dystrophy, congenital, LMNA-related
  • muscular dystrophy, limb-girdle, autosomal dominant
    • muscular dystrophy, limb-girdle, autosomal dominant 2
    • muscular dystrophy, limb-girdle, autosomal dominant 3
  • muscular dystrophy, limb-girdle, autosomal recessive
    • muscular dystrophy-dystroglycanopathy (limb-girdle), type C1
    • muscular dystrophy-dystroglycanopathy (limb-girdle), type C2
    • muscular dystrophy-dystroglycanopathy (limb-girdle), type C9
    • muscular dystrophy, limb-girdle, type 2C
    • muscular dystrophy, limb-girdle, type 2F
    • muscular dystrophy, limb-girdle, type 2H
    • muscular dystrophy, limb-girdle, type 2Z
  • muscular dystrophy, POMT1-related
    • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1
    • muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1
    • muscular dystrophy-dystroglycanopathy (limb-girdle), type C1
  • muscular dystrophy, POMT2-related
    • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2
    • muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2
    • muscular dystrophy-dystroglycanopathy (limb-girdle), type C2
  • muscular dystrophy, sarcoglycan-related D,G
    • muscular dystrophy, limb-girdle, type 2C
    • muscular dystrophy, limb-girdle, type 2F
  • muscular dystrophy, TRIM-gene-related
    • muscular dystrophy, limb-girdle, type 2H
  • muscular dystrophy-dystroglycanopathy
    • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1
    • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2
    • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9
    • muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1
    • muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2
  • myotonic dystrophy
    • myotonic dystrophy 1
    • myotonic dystrophy 2
  • oculopharyngeal muscular dystrophy
• Mycobacterium species infection
• myeloproliferative disorders, JAK2-related
• MYH9-related disorder
• myoclonic-atonic epilepsy
• myopathy, areflexia, respiratory distress, and dysphagia, early-onset
• myopathy, congenital
  • congenital myopathy 6 with ophthalmoplegia
  • congenital myopathy 7A, myosin storage, autosomal dominant
  • congenital myopathy 7B, myosin storage, autosomal recessive
  • myopathy, congenital, ACTA1-related
    • congenital myopathy 2C, severe infantile, autosomal dominant
    • nemaline myopathy 3
• myopathy, distal, 1
• myopathy, distal, 4
• myopathy, FLNC-related
• myopathy, lactic acidosis, and sideroblastic anemia
  • myopathy, lactic acidosis, and sideroblastic anemia 2
  • myopathy, lactic acidosis, and sideroblastic anemia 3
• myopathy, miR-9-related
• myopathy, MYH-class-II-related
  • cardiomyopathy, MYH6-MYH7-related
  • congenital myopathy 6 with ophthalmoplegia
  • congenital myopathy 7A, myosin storage, autosomal dominant
  • congenital myopathy 7B, myosin storage, autosomal recessive
• myopathy, myofibrillar
  • myopathy, myofibrillar, 2
  • myopathy, myofibrillar, 4
  • myopathy, myofibrillar, 5
• myopathy with extrapyramidal signs
• myopathy, statin-induced
• myopathy with rimmed vacuoles, TARDBP-related
• myotonic dystrophy
  • myotonic dystrophy 1
  • myotonic dystrophy 2
• nemaline myopathy
  • nemaline myopathy 3
  • nemaline myopathy 4
  • nemaline myopathy 7
• nephrotic syndrome
  • nephrotic syndrome, KANK-related
    • nephrotic syndrome, type 16
  • nephrotic syndrome, KIRREL-related
    • nephrotic syndrome, type 23
  • nephrotic syndrome, type 1
  • nephrotic syndrome, type 2
  • nephrotic syndrome, type 9
  • nephrotic syndrome, type 12
  • nephrotic syndrome, type 14
  • nephrotic syndrome, type 19
  • nephrotic syndrome, type 20
  • nephrotic syndrome, type 23
  • nephrotic syndrome related to coenzyme Q deficiency
  • nephrotic syndrome (postulated), GAPVD1-related
  • nephrotic syndrome (postulated), stomatin-related
• NESCAV syndrome
• Nestor-Guillermo progeria syndrome
• neural and muscular diseases (fly methods and biology)
• neural tube defect, VANGL1/2-related
• neuroblastoma, susceptibility to, 3
• neurodegeneration, activity dependent, DEGS-related
  • leukodystrophy, hypomyelinating, 18
• neurodegeneration, childhood-onset, with brain atrophy
• neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures
• neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset
• neurodegeneration with brain iron accumulation
  • neurodegeneration with brain iron accumulation 1
  • neurodegeneration with brain iron accumulation 2A
  • neurodegeneration with brain iron accumulation 2B
  • neurodegeneration with brain iron accumulation 4
  • neurodegeneration with brain iron accumulation 6
• neurodegenerative disease, ACOX1-related
  • Mitchell syndrome
  • peroxisomal acyl-CoA oxidase deficiency
• neurodegenerative disease, AFG3L2-related
  • optic atrophy 12
  • spastic ataxia 5, autosomal recessive
  • spinocerebellar ataxia 28
• neurodegenerative disease, arcRNA-related
• neurodegenerative disease, C19orf12-related
• neurodegenerative disease, CHCHD2,10-related
  • frontotemporal dementia and/or amyotrophic lateral sclerosis 2
  • Parkinson disease 22
  • spinal muscular atrophy, Jokela type
• neurodegenerative disease, FIG4-related
  • amyotrophic lateral sclerosis 11
  • Charcot-Marie-Tooth disease, type 4J
  • Yunis-Varon syndrome
• neurodegenerative disease, KIF5-related
• neurodegenerative disease, lysosomal-autophagy pathway, MITF-TFE-related
• neurodegenerative disease, miRNA-mediated glutamate receptor dysregulation in glia
• neurodegenerative disease, MME-related
  • Charcot-Marie-Tooth disease, type 2T
  • spinocerebellar ataxia 43
• neurodegenerative disease, NRDC-related
• neurodegenerative disease, PLA2G6-related
  • neurodegeneration with brain iron accumulation 2A
  • neurodegeneration with brain iron accumulation 2B
  • Parkinson disease 14
• neurodegenerative disease, PNPLA6-related
  • Boucher-Neuhauser syndrome
  • Leber congenital amaurosis (postulated), PNPLA6-related
  • Oliver-McFarlane syndrome
  • spastic paraplegia 39
• neurodegenerative disease, SLC25A39,40-related
• neurodegenerative disease, SQSTM1-related
  • frontotemporal dementia and/or amyotrophic lateral sclerosis 3
  • neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset
• neurodegenerative disease, UBQLN-related
• neurodegenerative disease, VPS13-related
  • chorea-acanthocytosis
  • Parkinson disease 23, early-onset
• neurodegenerative disease of CoA-mtACP-PDH pathway, NDUFAB1 model
• neurodegenerative disease (postulated), ABCG-related
• neurodegenerative disease (postulated), AMPK-related
• neurodegenerative disease (postulated), MIR137-related
• neurodegenerative disease (postulated), NPLOC4-related
• neurodegenerative disease (postulated), SLC17A/VGLUT-related
• neurodegenerative disease, susceptibility to, SOX5-related
• neurodegenerative disorders, ATP13A2-related
  • Kufor-Rakeb syndrome (PARK9)
  • spastic paraplegia 78
• neurodevelopmental disorder, DXH9-related
• neurodevelopmental disorder, EZH1-related
• neurodevelopmental disorder, GTPBP1/GTPBP2-related
• neurodevelopmental disorder, MRTFB-related
• neurodevelopmental disorder, NSUN6-related
• neurodevelopmental disorder, neural stem cell dedifferentiation
• neurodevelopmental disorder, PRPF19-related
• neurodevelopmental disorder, UNC79-related
• neurodevelopmental disorder (postulated), DROSHA-related
• neurodevelopmental disorder (postulated), WDR5-related
• neurodevelopmental disorder with cerebellar atrophy and motor dysfunction
• neurodevelopmental disorder with cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay
• neurodevelopmental disorder with developmental delay, hypotonia, and impaired language
• neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities
• neurodevelopmental disorder with dysmorphic facies and thin corpus callosum
• neurodevelopmental disorder with eye movement abnormalities and ataxia
• neurodevelopmental disorder with global developmental delay, DOT1L-related
• neurodevelopmental disorder with hypotonia and speech delay, with or without seizures
• neurodevelopmental disorder with intellectual disability, autistic features and language delay, with or without seizures
• neurodevelopmental disorder with intellectual disability, hypotonia, impaired speech, and dysmorphic facies
• neurodevelopmental disorder with language delay and seizures
• neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy
• neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities
• neurodevelopmental disorder with or without autism or seizures
• neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures
• neurodevelopmental disorder with severe developmental delay, intellectual disability, and behavioral abnormalities, CYFIP1-related
• neurodevelopmental disorder with spasticity and poor growth
• neurodevelopmental disorder with speech impairment and dysmorphic facies
• neurodevelopmental disorders, FAT4-related
  • Hennekam lymphangiectasia-lymphedema syndrome 2
  • Van Maldergem syndrome 2
• neurodevelopmental disorders, MECP2-related
  • encephalopathy, neonatal severe, MECP2-related
  • intellectual disability, X-linked, syndromic 13
  • intellectual disability, X-linked, syndromic, Lubs type
  • Rett syndrome
• neurodevelopmental disorders (postulated), TAOK-related
  • autism spectrum disorder, susceptibility to (postulated), TAOK2-related
    
  • chromosome 16p11.2 deletion syndrome, 593-kb
• neurodevelopmental disorders, susceptibility to (postulated), MIR22-related
• neurodevelopmental disorders, susceptibility to (postulated), RBFOX-related
• neurodevelopmental disorders, WDR81-related
• neurodevelopmental syndrome with mild facial dysmorphia, SMARCA5-related
• neurofibromatosis, type 1
• neurological and neurodegenerative disease, ubiquitin pathways
• neurological disorder with hypotonia, hyper-reflexia, ataxia, dystonia and white matter abnormalities, TOMM70-related
• neurological disorders, ATP6AP2-related
• neurological disorders, ATPalpha-related
  • migraine, familial hemiplegic 2
• neurological disorders, GNAO1-related
  • developmental and epileptic encephalopathy 17
• neurological disorders, MPV17-related
  • Charcot-Marie-Tooth disease, axonal, type 2EE
  • mitochondrial DNA depletion syndrome 6 (hepatocerebral type)
• neuromuscular disease, ATP2A-related
• neuromuscular disease, DCTN1-related
• neuromuscular disease, JPH-related
• neuromuscular disease, MARS2-related
• neuromuscular disease, MICU1-related
  • myopathy with extrapyramidal signs
• neuromuscular diseases, TRPV4-related
  • neuronopathy, distal hereditary motor, autosomal dominant 8
  • neuropathy, hereditary motor and sensory, type IIC
  • scapuloperoneal spinal muscular atrophy
• neuronal ceroid lipofuscinosis
  • neuronal ceroid lipofuscinosis 1
  • neuronal ceroid lipofuscinosis 3
  • neuronal ceroid lipofuscinosis 4
  • neuronal ceroid lipofuscinosis 7
  • neuronal ceroid lipofuscinosis 10
• neuronal intranuclear inclusion disease
• neuronal necrosis, calcium overload model
• neuronopathy, distal hereditary motor
  • neuronopathy, distal hereditary motor, autosomal dominant 4
  • neuronopathy, distal hereditary motor, autosomal recessive 8
  • neuronopathy, distal hereditary motor, autosomal dominant 2
  • neuronopathy, distal hereditary motor, autosomal dominant 3
  • neuronopathy, distal hereditary motor, autosomal dominant 5
  • neuronopathy, distal hereditary motor, autosomal dominant 14
  • neuronopathy, distal hereditary motor, autosomal dominant 8
  • neuronopathy, distal hereditary motor, X-linked
• neuronopathy, HSPB8-related
  • Charcot-Marie-Tooth disease, axonal, type 2L
  • neuronopathy, distal hereditary motor, autosomal dominant 2
• neurooculocardiogenitourinary syndrome
• neuropathy, ataxia, and retinitis pigmentosa
• neuropathy, hereditary sensory and autonomic
  • neuropathy, hereditary sensory and autonomic, type IA
  • neuropathy, hereditary sensory and autonomic, type IC
  • neuropathy, hereditary sensory and autonomic, type VIII
  • neuropathy, hereditary sensory, type IIC
• neuropathy, hereditary motor and sensory, type IIC
• neuropathy, hereditary motor and sensory, type VIA
• neuropathy, hereditary motor and sensory, type VIB
• NFIA-related disorder
• NGLY1 congenital disorder of deglycosylation
• Niemann-Pick disease
  • Niemann-Pick disease, type A and B
  • Niemann-Pick disease, type C1
  • Niemann-Pick disease, type C2
• night blindness, congenital stationary
  • night blindness, congenital stationary, 1B, autosomal recessive
• Nijmegen breakage syndrome
• nociceptive pain sensitization, injury-induced
• Noonan syndrome
  • Noonan syndrome 1
  • Noonan syndrome 3
  • Noonan syndrome 5
  • Noonan syndrome 7
• Noonan syndrome with multiple lentigines
  • Noonan syndrome with multiple lentigines 1
  • Noonan syndrome with multiple lentigines 2
• NSD1 duplication syndrome
• nystagmus, congenital
  • nystagmus 8, congenital, autosomal recessive
• obesity, susceptibility to (fly models overview)
  • age-dependent ectopic fat accumulation, HDAC6-related
  • diabetes/obesity, impact of parental disease
  • high-fat diet, obesity
  • high-sugar diet, obesity
  • insulin signaling, regulation of fat storage, Drosophila fat body model
  • leptin deficiency or dysfunction
  • obesity and behavioral phenotypes (postulated), ETV5-related
  • obesity and cardiomyocyte regulation of systemic lipid levels, APOB-related
  • obesity and cardiomyocyte regulation of systemic lipid levels, MTTP-related
  • obesity and cardiomyocyte regulation of systemic lipid levels, role of SNAIL TF genes
  • obesity and diabetes type 1, susceptibility to (postulated), ITPR-related
  • obesity and metabolic disorder, starvation-resistant populations
  • obesity and metabolic disorder, susceptibility to (postulated), MIR33-related
    
  • obesity model, activation of Taotie neurons
  • obesity model, prolonged larval stage
  • obesity, body-fat sensor mechanisms, semaphorin-related
  • obesity, susceptibility to, adipokinetic hormone model
  • obesity, susceptibility to, TFAP2B-KCTD15-CCK regulation of feeding behavior
  • obesity, susceptibility to (postulated), ABHD4/5-related
  • obesity, susceptibility to (postulated), ceramide/sphingolipid-related
  • obesity, susceptibility to (postulated), CAPN8-related
  • obesity, susceptibility to (postulated), CORO7-related
  • obesity, susceptibility to (postulated), DNAH10-related
  • obesity, susceptibility to (postulated), FLII-related
  • obesity, susceptibility to (postulated), hedgehog signaling pathway
  • obesity, susceptibility to (postulated), Hippo signaling pathway
  • obesity, susceptibility to (postulated), MED12-related
  • obesity, susceptibility to (postulated), MED13-related
  • obesity, susceptibility to (postulated), neurotensin-related
  • obesity, susceptibility to (postulated), NKX6-3-related
  • obesity, susceptibility to (postulated), PLIN-related
  • obesity, susceptibility to (postulated), PLXND1-related
  • obesity, susceptibility to (postulated), PNPLA/ATGL-related
  • obesity, susceptibility to (postulated), SDK1-related
  • obesity, susceptibility to (postulated), SEC16B-related
  • obesity, susceptibility to (postulated), serotonin class 2 receptor(s)
  • obesity, susceptibility to (postulated), SNCAIP-related
  • obesity, susceptibility to (postulated), SPEN-related
  • obesity, susceptibility to (postulated), STIM1-related
  • obesity, susceptibility to (postulated), THADA-related
  • obesity, susceptibility to (postulated), WDTC1-related
  • obesity, susceptibility to (postulated), Wnt signaling pathway
• occipital horn syndrome
• oculopharyngeal muscular dystrophy
• Oliver-McFarlane syndrome
• operant self-learning disorders, FOXP-related
  • intellectual disability with language impairment and with or without autistic features
  • speech-language disorder 1
• optic atrophy
  • optic atrophy syndromes, OPA1-related
    • optic atrophy 1
  • optic atrophy 12
    • optic atrophy plus syndrome
• organophosphate-induced delayed neuropathy
• ovarian dysgenesis
  • ovarian dysgenesis 6
  • ovarian dysgenesis 7
  • ovarian dysgenesis (postulated), BRCA2-related
• oxoglutarate dehydrogenase deficiency
• pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures
• pancreatic carcinoma, multigenic
• pancreatic islet amyloidosis, IAPP-related
• panhypopituitarism, X-linked, with or without intellectual disability
• Parkinson disease
  • Parkinson disease 1
  • Parkinson disease 2, early-onset
  • Parkinson disease 4
  • Parkinson disease 5, susceptibility to
  • Parkinson disease 6, early-onset
  • Parkinson disease 7, early-onset
  • Parkinson disease 8
  • Parkinson disease 11, susceptibility to
  • Parkinson disease 13, susceptibility to
  • Parkinson disease 14
  • Parkinson disease 15, early-onset
  • Parkinson disease 16 (postulated), RAB29-related
  • Parkinson disease 17
  • Parkinson disease 19A/B, early-onset
  • Parkinson disease 20, early-onset
  • Parkinson disease 22
  • Parkinson disease 23, early-onset
  • Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development
  • Parkinson disease (postulated), BOK-related
  • Parkinson disease (postulated), DNAJC13-related
  • Parkinson disease (postulated), FOXO-related
  • Parkinson disease (postulated), GPR37-related
  • Parkinson disease (postulated), IMMT-related
  • Parkinson disease (postulated), NSF-related
  • Parkinson disease (postulated), NUS1-related
  • Parkinson disease (postulated), PAK4-related
  • Parkinson disease (postulated), PGC-1-related
  • Parkinson disease (postulated), SNCAIP-related
  • Parkinson disease (postulated), TMEM230-related
  • Parkinson disease (postulated), TPPP-related
  • Parkinson disease (postulated), ZNF746-related
  • Parkinson disease, susceptibility plus toxin exposure
  • Parkinson disease, susceptibility to, AP2M1-related
  • Parkinson disease, susceptibility to, auxilin-related
  • Parkinson disease, susceptibility to, GBA1-related
  • Parkinson disease, susceptibility to, SH3GL2-related
  • Parkinson disease, susceptibility to, SREBF1-related
  • parkinsonism with polyneuropathy
• Parkinson disease, iron overload
• Parkinson-like disease, BPA-induced
• Parkinson-like disease, metal toxicity
• Parkinson-like disease, MPP-induced
• Parkinson-like disease, toxin-induced
• Parkinson-like disease (postulated), HSPA9-related
• Parkinson-like model, Dmel_Fer2
• Parkinson-like model, PGK-related
• Parkinson-like model, proteasome-related
• Parkinson-like model, RHOT/Miro-related
• parkinsonism-dystonia, infantile 1
• paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy
• Perlman syndrome
• peripheral neuropathy, drug-induced
• peroxisomal acyl-CoA oxidase deficiency
• peroxisome biogenesis disorder
  • peroxisome biogenesis disorder 1A
  • peroxisome biogenesis disorder 2A
  • peroxisome biogenesis disorder 3A
  • peroxisome biogenesis disorder 4A
  • peroxisome biogenesis disorder 5A
  • peroxisome biogenesis disorder 6A
  • peroxisome biogenesis disorder 8A
  • peroxisome biogenesis disorder 9B
  • peroxisome biogenesis disorder 10A
  • peroxisome biogenesis disorder 11A
  • peroxisome biogenesis disorder 12A
  • peroxisome biogenesis disorder 13A
  • peroxisome biogenesis disorder 14B
• Perry syndrome
• persistent alcohol cue memory
• Pick disease
• pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
• Pitt-Hopkins syndrome
• Pitt-Hopkins-like syndrome 1
• Pitt-Hopkins-like syndrome 2
• pituitary adenoma 1, multiple types
• polyalanine diseases
  • oculopharyngeal muscular dystrophy
• polycystic kidney disease
  • polycystic kidney disease 2
• polyglutamine diseases
  • dentatorubral-pallidoluysian atrophy
  • Huntington disease
  • Machado-Joseph disease (SCA3)
  • spinal and bulbar muscular atrophy, X-linked 1
  • spinocerebellar ataxia 1
  • spinocerebellar ataxia 2
  • spinocerebellar ataxia 7
    
  • spinocerebellar ataxia 8
  • spinocerebellar ataxia 12
  • spinocerebellar ataxia 17
• polyglutamine diseases, polyQ models
• pontocerebellar hypoplasia
  • pontocerebellar hypoplasia, type 1B
  • pontocerebellar hypoplasia, type 2A
  • pontocerebellar hypoplasia, type 4
  • pontocerebellar hypoplasia, type 5
  • pontocerebellar hypoplasia, type 10
  • pontocerebellar hypoplasia, TSEN54-related
• porphyria-like (postulated), GBE1-related
• primary ovarian insufficiency
  • primary ovarian insufficiency (postulated), MOV10-related
• prion diseases
  • Creutzfeldt-Jakob disease, familial
  • fatal familial insomnia
  • Gerstmann-Straussler disease
• progeroid syndrome
  • Hutchinson-Gilford progeria syndrome
  • Nestor-Guillermo progeria syndrome
  • Werner syndrome
• progressive external ophthalmoplegia with mtDNA deletions
  • progressive external ophthalmoplegia with mtDNA deletions, autosomal dominant 1
  • progressive external ophthalmoplegia with mtDNA deletions, autosomal dominant 3
  • progressive external ophthalmoplegia with mtDNA deletions, autosomal dominant 4
  • progressive external ophthalmoplegia with mtDNA deletions, autosomal recessive 1
• progressive external ophthalmoplegia with mtDNA deletions, autosomal dominant 2
• progressive supranuclear palsy 1
• proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome
• prosaposin deficiency
• prostate cancer
  • prostate cancer, E-cadherin-related
  • prostate cancer, N-cadherin-related
  • prostate cancer, PAX-related
  • prostate cancer model, Drosophila cell culture exposed to synthetic androgen
  • prostate cancer (postulated), astacin-related
  • prostate cancer (postulated), CNPY1,2-related
  • prostate cancer (postulated), MRGBP-related
• pseudohypoaldosteronism, type II
  • pseudohypoaldosteronism, type II, WNK-related
    • pseudohypoaldosteronism, type IIB
    • pseudohypoaldosteronism, type IIC
• Pseudomonas aeruginosa infection
• pyridoxamine 5'-phosphate oxidase deficiency
• pyruvate dehydrogenase complex deficiency
  • pyruvate dehydrogenase E1-beta deficiency
• RASopathies, MAP2K1,2-related
  • cardiofaciocutaneous syndrome 3
  • cardiofaciocutaneous syndrome 4
• reducing body myopathy 1A
• renal fibrosis, steroid-induced
• Renpenning syndrome 1
• restless legs syndrome
  • restless legs syndrome 6 (postulated), BTBD9-related
• retinal disease, inherited (fly models overview)
  • cone-rod dystrophy
    • cone-rod dystrophy 2
    • cone-rod dystrophy 12
  • Leber congenital amaurosis
    • Leber congenital amaurosis 7
    • Leber congenital amaurosis 8
    • Leber congenital amaurosis (postulated), PNPLA6-related
  • Leber hereditary optic neuropathy
    • Leber hereditary optic neuropathy, MT-ND2-related
  • macular retinal dystrophy, North Carolina type, PRDM13-related
  • retinal degeneration, excessive endocytosis of rhodopsin
  • retinal disease, CRB1-related
    • Leber congenital amaurosis 8
    • retinitis pigmentosa 12
  • retinal disease, CRX-related
    • cone-rod dystrophy 2
    • Leber congenital amaurosis 7
  • retinal disease, PROM1-related
    • cone-rod dystrophy 12
    • retinal macular dystrophy 2
    • retinitis pigmentosa 41
  • retinal disease, rhodopsin-related
    • retinitis pigmentosa 4
  • retinitis pigmentosa
    • retinitis pigmentosa 4
    • retinitis pigmentosa 11
    • retinitis pigmentosa 12
    • retinitis pigmentosa 13
    • retinitis pigmentosa 25
    • retinitis pigmentosa 41
    • retinitis pigmentosa 59
• Rett syndrome
• rhabdoid tumor predisposition syndrome 1
• rhabdomyosarcoma 2, PAX7-FOXO1 fusion
• rhabdomyosarcoma 2, PAX3-FOXO1 fusion
• riboflavin transporter deficiency neuronopathy
  • Brown-Vialetto-Van Laere syndrome 1
  • Brown-Vialetto-Van Laere syndrome 2
• RNA repeat diseases
  • fragile-X-related syndromes
    • fragile X syndrome
    • fragile X tremor/ataxia syndrome
  • Friedreich ataxia 1
  • frontotemporal dementia and/or amyotrophic lateral sclerosis 1
  • myotonic dystrophy 1
  • myotonic dystrophy 2
  • spinocerebellar ataxia 8
  • spinocerebellar ataxia 10
• Robinow syndrome, autosomal dominant 2
• Salmonella species infection
• Sandestig-Stefanova syndrome
• SARS-CoV-1,2 viral infection
• scapuloperoneal spinal muscular atrophy
• schizophrenia, susceptibility to
  • schizophrenia, dopamine ontogeny hypothesis
  • schizophrenia, susceptibility to, DISC1-related
  • schizophrenia, susceptibility to (postulated), BLOC1S1-related
  • schizophrenia, susceptibility to (postulated), DTNBP1-related
  • schizophrenia, susceptibility to (postulated), RIMS-related
• Schimke immuno-osseous dysplasia
• schwannomatosis, vestibular
• Seckel syndrome 9
• seizures, benign familial infantile
  • seizures, benign familial infantile, 3
• seizure-sensitive (postulated), ETNK-related
• seizure-sensitive (postulated), SLC12A1-3-related
• seizure-sensitive (postulated), SLC24A-related
• seizure-sensitive, potassium channel defects (eag, Sh model)
• seizure-sensitive, potassium channel defects, KCNT1-2-related
  • developmental and epileptic encephalopathy 14
  • developmental and epileptic encephalopathy 57
  • epilepsy, nocturnal frontal lobe, 5
• seizure-sensitive (postulated), UBE3A-related
• seizure sensitive/resistant (postulated), PRKG1-related
• seizure sensitivity, disruption during critical developmental period
• seizure-sensitivity model, Dmel_jus
• sensory ataxic neuropathy, dysarthria, and ophthalmoparesis
• Serratia marcescens infection
• short stature, hearing loss, retinitis pigmentosa, and distinctive facies
• Shwachman-Diamond syndrome 1
• Siddiqi syndrome
• Sindbis virus infection
• SLC5A6-related disorders
• Sotos syndrome 1
• spastic ataxia
  • spastic ataxia 3, autosomal recessive
  • spastic ataxia 5, autosomal recessive
• spastic paraplegia
  • dystonia, early-onset, and/or spastic paraplegia
  • spastic paraplegia 3A
  • spastic paraplegia 4
  • spastic paraplegia 7
  • spastic paraplegia 10
  • spastic paraplegia 12
  • spastic paraplegia 15
  • spastic paraplegia 17
  • spastic paraplegia 20
  • spastic paraplegia 30
  • spastic paraplegia 31, autosomal dominant
  • spastic paraplegia 35
  • spastic paraplegia 39
  • spastic paraplegia 43
  • spastic paraplegia 61
  • spastic paraplegia 76
  • spastic paraplegia 77
  • spastic paraplegia 78
  • spastic paraplegia 90A, autosomal dominant
• spinal muscular atrophy
  • motor neuron disease (postulated), WRAP53-related
  • neuronopathy, distal hereditary motor, X-linked
  • spinal and bulbar muscular atrophy, X-linked 1
  • spinal muscular atrophy, Jokela type
  • spinal muscular atrophy, late onset, Finkel type
  • spinal muscular atrophy, lower extremity-predominant, 2
  • spinal muscular atrophy, SMN-related
    • spinal muscular atrophy, type I
    • spinal muscular atrophy, type II
    • spinal muscular atrophy, type III
    • spinal muscular atrophy, type IV
    • spinal muscular atrophy, SMN2-related therapy
• spinocerebellar ataxia, autosomal dominant
  • dentatorubral-pallidoluysian atrophy
  • global developmental delay and congenital ataxia, CACNA1A-related
  • Machado-Joseph disease (SCA3)
  • spinocerebellar ataxia 1
  • spinocerebellar ataxia 2
  • spinocerebellar ataxia 5
  • spinocerebellar ataxia 6
  • spinocerebellar ataxia 7
  • spinocerebellar ataxia 8
  • spinocerebellar ataxia 10
  • spinocerebellar ataxia 12
  • spinocerebellar ataxia 13
  • spinocerebellar ataxia 14
  • spinocerebellar ataxia 15
  • spinocerebellar ataxia 17
  • spinocerebellar ataxia 28
  • spinocerebellar ataxia 29
  • spinocerebellar ataxia 31
  • spinocerebellar ataxia 35
  • spinocerebellar ataxia 43
• spinocerebellar ataxia, autosomal recessive
  • neurodevelopmental disorder with spasticity and poor growth
  • spinocerebellar ataxia autosomal recessive 4
  • spinocerebellar ataxia autosomal recessive 14
  • spinocerebellar ataxia autosomal recessive 21
  • spinocerebellar ataxia autosomal recessive 24 (postulated)
  • spinocerebellar ataxia autosomal recessive 25 (postulated)
  • spinocerebellar ataxia autosomal recessive 27
  • spinocerebellar ataxia autosomal recessive 32
  • spinocerebellar ataxia autosomal recessive (postulated), UFM1-related
• spinocerebellar ataxia, autosomal recessive, with axonal neuropathy
  • spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
  • spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3
• spondyloarthropathy, susceptibility to
  • spondyloarthropathy, susceptibility to, 1
• Staphylococcus aureus infection
• Stolerman neurodevelopmental syndrome
• Streptococcus species infection
• striatonigral degeneration, infantile, mitochondrial
• sulfite oxidase deficiency, isolated
• synaptic dysfunction, KIF1-related
  • NESCAV syndrome
  • neuropathy, hereditary sensory, type IIC
  • spastic paraplegia 30
• synaptic transmission defects, IDH3A-related
• TANGO2-related metabolic encephalopathy and arrhythmias
• tauopathies
  • tauopathies, heterochromatin decondensation and transposable element dysregulation
  • tauopathies, MAPT-related
    • frontotemporal dementia with parkinsonism 17
    • Pick disease
    • progressive supranuclear palsy 1
• TBC1D24-related disorders
  • DOORS syndrome
  • epilepsy, rolandic, with paroxysmal exercise-induced dystonia
• thyroid carcinoma, familial medullary
  • multiple endocrine neoplasia
• thyroid carcinoma, nonmedullary
• Townes-Brocks syndrome
• toxicity studies (fly models overview)
• traumatic brain injury and chronic traumatic encephalopathy
• trichothiodystrophy
  • trichothiodystrophy 1, photosensitive
• triosephosphate isomerase deficiency
• tuberous sclerosis complex
  • tuberous sclerosis 1
  • tuberous sclerosis 2
• type IV collagenopathies
• ulcerative colitis-like, chemically induced
• uric acid nephrolithiasis, Dmel_CG10939 model
• Usher syndrome
  • Usher syndrome, type I
  • Usher syndrome, type IJ
• Usher syndrome, deafness, MYO7A-related
  • deafness, autosomal dominant 11
  • deafness, autosomal recessive 2
  • Usher syndrome, type I
• Van Maldergem syndrome 2
• vertebral anomalies and variable endocrine and T-cell dysfunction
• vertebral hypersegmentation and orofacial anomalies
• Vibrio cholerae infection
• Vici syndrome
• viral infection, susceptibility to (postulated), EHMT-related
• visceral myopathy (postulated), MSTO1-related
• visual impairment and progressive phthisis bulbi
• Vissers-Bodmer syndrome
• von Hippel-Lindau syndrome
• Wallerian degeneration
• Warburg micro syndrome
  • Warburg micro syndrome 2
• Werner syndrome
• WFS1-related disorders
  • Wolfram syndrome 1
• White-Sutton syndrome
• Williams-Beuren syndrome
  • Williams-Beuren syndrome, LIMK1-related
• Wilson disease
• Wolfram syndrome 1
• xanthinuria, type I
• xeroderma pigmentosum
  • xeroderma pigmentosum, complementation group B
  • xeroderma pigmentosum, complementation group D
  • xeroderma pigmentosum, variant type
• Yoon-Bellen neurodevelopmental syndrome
• Yunis-Varon syndrome